Insulin resistance is a critical factor in the pathogenesis of Type 2 Diabetes and cardiovascular diseases, and is due to impaired stimulation of glucose uptake in skeletal muscle. Insulin resistance is also associated with abnormalities in fat metabolism that exist independent of the degree of generalized obesity, including elevated circulating free fatty acids and increased accumulation of intramuscular lipid. Our central hypothesis is that the accumulation of intramyocellular lipid (IML) involves defects muscle fat metabolism, and is integrally related to impaired function of the glucose transport system. Our goal is for the first time to elucidate the molecular basis of abnormal muscle lipid metabolism in insulin resistant humans. Study groups include both lean and obese insulin-sensitive and - resistant individuals to discriminate between effects of obesity and insulin resistance, treatment with troglitazone and dexamethasone, and Type 2 diabetics before and after intensive euglycemic therapy.
In specific aim 1, we will examine the relationship between insulin resistance and increased intramuscular lipid, and whether lipid accumulation is due to a relative defect in oxidation and/or an increase in FFA delivery. These studies will employ hyperinsulinemic clamps, palmitate turnover, AV leg balance studies, and whole-body and leg indirect calorimetry. IML will be assessed by histology and proton NMR spectroscopy.
In specific aim 2, carnitine palmitoyltransferase 1 (CPT1), malonyl CoA, and acetyl CoA carboxylase will be examined in skeletal muscle as critical determinants of fuel partitioning and insulin sensitivity.
In specific aim 3, in situ microdialysis will be used to study the role of TNFalpha as an autocrine/paracrine factor in regulating fatty acid metabolism and insulin sensitivity in adipose and muscle tissues The hypotheses are that dysregulation of this fuel sensing apparatus will reduce muscle CPT1 activity, inhibit entry and oxidation of long chain acyl CoAs in mitochondria, and promote accumulation of IML.
Specific aim 4 will assess structure/function relationships for novel common polymorphisms in the muscle CPT1 gene that are associated with hyperglycemia, hyperinsulinemia, and insulin resistance. Fat metabolism, IML, CPT1 activity, and insulin sensitivity will be examined in vivo as a function of genotype, and specific activity of CPT1 variants will be assessed expressed in yeast. These experiments will for the first time examine relationships between muscle fat metabolism, IML, TNFalpha and insulin sensitivity in humans.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK038765-13A2
Application #
6199537
Study Section
Endocrinology Study Section (END)
Program Officer
Laughlin, Maren R
Project Start
2000-09-15
Project End
2005-06-30
Budget Start
2000-09-15
Budget End
2001-06-30
Support Year
13
Fiscal Year
2000
Total Cost
$368,136
Indirect Cost
Name
Medical University of South Carolina
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425
Kang, Minsung; Liu, Xiaobing; Fu, Yuchang et al. (2018) Improved systemic metabolism and adipocyte biology in miR-150 knockout mice. Metabolism 83:139-148
Ma, Elizabeth; Fu, Yuchang; Garvey, W Timothy (2018) Relationship of Circulating miRNAs with Insulin Sensitivity and Associated Metabolic Risk Factors in Humans. Metab Syndr Relat Disord 16:82-89
Guo, Fangjian; Garvey, W Timothy (2017) Cardiometabolic Disease Staging Predicts Effectiveness of Weight-Loss Therapy to Prevent Type 2 Diabetes: Pooled Results From Phase III Clinical Trials Assessing Phentermine/Topiramate Extended Release. Diabetes Care 40:856-862
Garvey, W Timothy (2017) Comment on Cefalu et al. Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum. Diabetes Care 2016;39:1186-1201. Diabetes Care 40:e21-e22
Ma, Elizabeth; Ingram, Katherine H; Milne, Ginger L et al. (2017) F2-Isoprostanes Reflect Oxidative Stress Correlated With Lean Mass and Bone Density but Not Insulin Resistance. J Endocr Soc 1:436-448
Zhang, Wei; Hartmann, Riley; Tun, Hein Min et al. (2016) Deletion of the Toll-Like Receptor 5 Gene Per Se Does Not Determine the Gut Microbiome Profile That Induces Metabolic Syndrome: Environment Trumps Genotype. PLoS One 11:e0150943
Steverson Jr, Dennis; Tian, Ling; Fu, Yuchang et al. (2016) Tribbles Homolog 3 Promotes Foam Cell Formation Associated with Decreased Proinflammatory Cytokine Production in Macrophages: Evidence for Reciprocal Regulation of Cholesterol Uptake and Inflammation. Metab Syndr Relat Disord 14:7-15
Chandler-Laney, Paula C; Schneider, Camille R; Gower, Barbara A et al. (2016) Association of late-night carbohydrate intake with glucose tolerance among pregnant African American women. Matern Child Nutr 12:688-98
Garvey, W Timothy (2016) Ablation of the Duodenal Mucosa as a Strategy for Glycemic Control in Type 2 Diabetes: Role of Nutrient Signaling or Simple Weight Loss. Diabetes Care 39:2108-2110
Zhang, Wei; Wu, Mengrui; Kim, Teayoun et al. (2016) Skeletal Muscle TRIB3 Mediates Glucose Toxicity in Diabetes and High- Fat Diet-Induced Insulin Resistance. Diabetes 65:2380-91

Showing the most recent 10 out of 33 publications